7.47
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$7.58
Offen:
$7.555
24-Stunden-Volumen:
6.38M
Relative Volume:
0.98
Marktkapitalisierung:
$1.21B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$422.82M
KGV:
3.2763
EPS:
2.28
Netto-Cashflow:
$-637.33M
1W Leistung:
-4.72%
1M Leistung:
+6.56%
6M Leistung:
+5.81%
1J Leistung:
-34.47%
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NVAX
Novavax Inc
|
7.47 | 1.23B | 1.08B | 422.82M | -637.33M | 2.28 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
2025-06-17 | Eingeleitet | Citigroup | Sell |
2025-02-28 | Eingeleitet | BTIG Research | Buy |
2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
2023-01-09 | Bestätigt | B. Riley Securities | Buy |
2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
2022-12-02 | Eingeleitet | Jefferies | Hold |
2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
2022-05-20 | Eingeleitet | BofA Securities | Underperform |
2022-02-23 | Bestätigt | B. Riley Securities | Buy |
2022-02-22 | Fortgesetzt | Jefferies | Buy |
2022-01-21 | Eingeleitet | Cowen | Outperform |
2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
2020-12-14 | Eingeleitet | Jefferies | Buy |
2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2020-06-29 | Bestätigt | B. Riley FBR | Buy |
2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
2020-05-28 | Bestätigt | B. Riley FBR | Buy |
2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax Inc. recovery potential after sell offWeekly Gains Summary & Smart Investment Allocation Tips - Newser
How high can Novavax Inc. stock goInsider Buying & Daily Entry Point Trade Alerts - Newser
Is Novavax Inc. trending in predictive chart modelsWatch List & Free Expert Verified Stock Movement Alerts - Newser
Candlestick signals on Novavax Inc. stock today2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Can machine learning forecast Novavax Inc. recovery2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
Price momentum metrics for Novavax Inc. explainedIndex Update & Free Technical Confirmation Trade Alerts - Newser
Novavax Initiates Coverage with Buy Rating and $10 Price Target - AInvest
What earnings revisions data tells us about Novavax Inc.July 2025 Highlights & Reliable Breakout Forecasts - Newser
Will Novavax Inc. stock go up soonEarnings Growth Report & Real-Time Volume Analysis - Newser
Using RSI to spot recovery in Novavax Inc.July 2025 Final Week & Reliable Momentum Entry Alerts - Newser
Why Novavax Inc. stock attracts strong analyst attentionJuly 2025 Volume & Consistent Profit Trading Strategies - Newser
How moving averages guide Novavax Inc. tradingAnalyst Upgrade & Stepwise Trade Execution Plans - Newser
Is Novavax Inc. Forming a Bottom Pattern2025 Bull vs Bear & Target Return Focused Picks - beatles.ru
How to monitor Novavax Inc. with trend dashboardsPrice Action & Daily Oversold Stock Bounce Ideas - Newser
What to expect from Novavax Inc. in the next 30 daysGDP Growth & Verified High Yield Trade Plans - Newser
Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA - MSN
Novavax Inc. stock daily chart insightsMarket Weekly Review & AI Powered Buy/Sell Recommendations - Newser
Novavax Inc.’s volatility index tracking explainedProfit Target & AI Powered Market Entry Strategies - Newser
Full technical analysis of Novavax Inc. stockRisk Management & Long Hold Capital Preservation Tips - Newser
What to do if you’re stuck in Novavax Inc.Recession Risk & Verified Momentum Watchlists - Newser
Analyzing Novavax Inc. with multi timeframe chartsAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - Newser
Can technical indicators confirm Novavax Inc.’s reversalDollar Strength & Long-Term Growth Portfolio Plans - Newser
Using data filters to optimize entry into Novavax Inc.Layoff News & Growth Focused Stock Reports - Newser
Momentum divergence signals in Novavax Inc. chartQuarterly Risk Review & Weekly Top Gainers Alerts - Newser
What technical models suggest about Novavax Inc.’s comebackEarnings Risk Report & Expert Approved Trade Ideas - Newser
Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. - Eastern Progress
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novavax Inc-Aktie (NVAX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Alton Gregg H | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
28,805 |
King Rachel K. | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,190 |
Rodgers Richard J | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
24,690 |
MOTT DAVID M | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
60,890 |
DOUGLAS RICHARD | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
54,340 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):